Among those, JAK3 mutations were frequent (14%) and preferentially found in the early (19%) and mature (20%) subgroups compared to thymic T-ALL (8%, n.s., Table 1, Figure 1 and 2). Here, JAK3 is linked to acute lymphoblastic leukemia.